Emerging Blood-Based Biomarkers for Predicting Immunotherapy Response in NSCLC

SIMPLE SUMMARY: Treatment with immunotherapy has been established as a standard treatment for lung cancer in recent years. Unfortunately, still, only a small proportion of patients benefit from the treatment, being the first leading cause of cancer death worldwide. Therefore, there is an urgent need...

Descripción completa

Detalles Bibliográficos
Autores principales: Oitabén, Ana, Fonseca, Pablo, Villanueva, María J., García-Benito, Carme, López-López, Aida, Garrido-Fernández, Alberto, González-Ojea, Clara, Juaneda-Magdalena, Laura, Lázaro, Martín E., Martínez-Fernández, Mónica
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9179588/
https://www.ncbi.nlm.nih.gov/pubmed/35681606
http://dx.doi.org/10.3390/cancers14112626

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9179588/
https://www.ncbi.nlm.nih.gov/pubmed/35681606
http://dx.doi.org/10.3390/cancers14112626

Ejemplares similares